TGFB1 and neoplasm: However, with tumor progression, the components of the TGF-β signaling pathway, including receptors and Smad proteins, are mutated and deactivated, which cannot cause changes in c-myc, ID-1, and ID-2, and its growth inhibition is ineffective [45].